The Glenmark Pharmaceuticals Inc USA Data Breach: Incident Facts and Free Case Review
Glenmark Pharmaceuticals Inc USA is a global pharmaceutical company specializing in the research, development, and manufacturing of generic and specialty medications. As a healthcare-adjacent entity, the company routinely collects and maintains sensitive personal information, including patient health data, prescription records, and insurance details necessary for drug distribution and clinical support. In 2026, the company officially reported a data security incident to the Indiana Attorney General, confirming that unauthorized access to their systems occurred. If you received a data breach notification letter from Glenmark Pharmaceuticals, it indicates that your personal or health-related information may have been compromised. This notification is intended to inform you of the incident and provide guidance on the steps you should take to protect your identity and medical privacy.
- State
- Indiana
- Breach date
- February 27, 2026
- Reported
- March 17, 2026
What to do if you were affected
These general steps can help limit the risk of identity theft and fraud after any data breach.
Stay alert to targeted scams
Be cautious of calls, texts, or emails that reference this breach. Legitimate organizations won't ask you to confirm sensitive details through an unsolicited message.
Keep your notification letter
Save the notice you received. It documents that your information was involved and is often needed to enroll in any credit monitoring offered or to join a related legal claim.
Related data breach cases
- Bozeman School District
- Teamsters Local 17
- Bank
- American Vanguard Corporation
- Graphic Information Systems Inc
- Arcadia of Benton LLC
- Arcadia of Bowling Green LLC
- Arcadia of Clarksville LLC
- Arcadia of Elizabethtown LLC
- Arcadia of Louisville LLC
- Hahn Loeser & Parks LLP
- Mather & Co CPAs LLC
- Graymont Inc
- Active Leadgen LLC dba ukvisaportal.com